MYD88 L265P mutation in Waldenstrom macroglobulinemia

Key Findings

• ●MYD88 L265P acquired in 79% of WM patients by Sanger sequencing
• ●MYD88 locus altered in 91% including copy number gains at 3p22
• ●MYD88 mutations activate NF-kB signaling

Referenced in (1 disease)

1. passsource metadataJun 1, 2026, 04:40 PMby pubmed-api

   Stored DOI was incorrect; corrected to the PubMed-registered DOI (verified to resolve to this article).

   tools: pubmed.esummary, crossref.works